openPR Logo
Press release

XClinical’s review of 2010

02-15-2011 01:03 PM CET | IT, New Media & Software

Press release from: XClinical GmbH

XClinical GmbH

XClinical GmbH

XClinical looks back on an innovative and extremely successful year

XClinical GmbH, Munich, Germany – February 15th, 2011 – XClinical, European vendor of innovative software products for eClinical trials, well known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, had a very successful and innovative business year.

Extended workforce

Constant growth in the past years and the successful market relaunch of the STUDY COMPOSER as a standalone software tool at the beginning of 2010 has allowed XClinical to adapt its staffing situation to the favourable conditions and thus six new colleagues joined the corporate workforce. “The enlarged team enables us to develop our products more target-oriented and to support our customers even more comprehensively,” comments Dr. Philippe Verplancke, CEO and QM at XClinical. The changes within XClinical were also made visible to the outside: Marketing Department renewed the Corporate Design including the relaunch of the company website and existing marketing materials, reworked the company’s concept for conference appearance and implemented an official newsletter.

Continuous growth

Despite - or even because of - the efforts of integrating new staff into an existing team and existing workflows, XClinical experienced continuous growth and was able to expand its existing markets in the US, Europe and Asia. Both new and existing clients started about 45 new projects in 2011. To a large extend, this is owed to the company’s frequent participation in international pharmaceutical and data management events to establish contact with the industry worldwide. “It’s not only that we attend those conferences as exhibitors and speakers. Last year we also hosted the 2nd XClinical End-to-End Workshop. In our opinion, being a software provider also means sharing previous experience.” says Dr. Verplancke. “And it also means providing a platform for our clients to share their experience and to enter into dialogue with us. Last year we hosted the 6th XClinical User Meeting, which again was extremely successful.”

Affirmation of work by FDA’s future development plans

Last year XClinical received affirmation of its work by the FDA (Federal Drug Association). In the second half of 2010 the FDA announced to intensify the development of a data standard for electronic submission. XClinical experts see their opinion reconfirmed by the FDA’s approach to use CDISC standards for e-submission in the foreseeable future. “The FDA’s plan to reconsider the CDISC ODM standard in particular for e-submission really validates our approach. Our EDC System MARVIN and our eCRF design tool STUDY COMPOSER are both CDISC-compliant,” claims the CEO of XClinical.

Future Prospects

In 2011, XClinical aims at maintaining last year’s success. With the planned recruitment of more new employees, particularly in the software development department, XClinical strives to meet market requirements, develop new products and refine existing ones.
Motivated by last year’s workshop success, XClinical is planning to host a workshop specially designed for CEOs of contract research organizations and will also reissue the End-To-End workshop. ”Having dedicated this much energy to the restructuring and expansion of our team, we have built the foundations for the expansion of last year’s success”, says Dr. Verplancke.

About XClinical
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM-certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM).

XClinical GmbH
Siegfriedstrasse 8
80803 Munich
Katharina Lang
Phone: +49 (0)89 / 45 22 77 – 5220
Email: press@xclinical.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release XClinical’s review of 2010 here

News-ID: 162591 • Views: 1989

More Releases from XClinical GmbH

XClinical integrates INCA, Medical Coding software, with its EDC system MARVIN
XClinical releases version 1.6. of its coding system INCA XClinical GmbH, Munich, Germany, May 8, 2014 – XClinical, a global provider of eClinical solutions, today announces the availability of INCA version 1.6, medical coding software featuring MedDRA and WHODrug dictionaries, including an automated web interface to EDC systems such as MARVIN. INCA (“Integrated Coding Architecture”) is a web-based application that enables users to classify health related data such as patient medications and
XClinical CRO Executive Forum
XClinical hosts its first CRO Executive Forum on May 10, 2011 in Aying, Germany. XClinical GmbH, Munich, Germany – April 14, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, hosts its first CRO Executive Forum especially designed for CEOs of CROs on May 10, 2011 in Aying, Germany. The concept In 2010, XClinical started to provide
XClinical’s “MARVIN4KIDS” at the DIA Geneva
XClinical presents the initiative “MARVIN4KIDS” at the DIA Annual EuroMeeting in Geneva XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the initiative “MARVIN4KIDS” for the first time at the DIA Annual EuroMeeting in Geneva. The conference takes place from March 28 to 30. “MARVIN4KIDS” MARVIN4KIDS is an XClinical
XClinical and IDDI: The best of 2 worlds
The IWR/IVR system ID-netTM developed by IDDI now provides an interface to MARVIN, XClinical’s EDC system XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the web-based open interface of IDDI’s ID-netTM to XClinical’s EDC system MARVIN at the DIA Annual EuroMeeting in Geneva. About ID-netTM ID-netTM

All 5 Releases


More Releases for Clinical

Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Nutrition Conference 2018
Clinical nutrition is essential for patients in healthcare to deal with sickness, injuries, surgery and for proper recovery. It helps in preventing malnutrition, restoring body tissue and boosting energy and immunity in the body. It can be provided with a proper diet plan and feeding the patient with essential foods that revive the patient’s body the patient can also be given healthy supplements for proteins, vitamins etc. The preferred route
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
Europe Clinical Nutrition Market
According to the report “Europe Clinical Nutrition Market,” published by Market Data Forecast, the global market is projected to reach USD 12.45 billion by 2021 from USD 9.65 billion in 2016, at a CAGR of 5.29% from 2016 to 2021. Clinical nutrition is the practice of analysing if a person is consuming an adequate amount of nutrients for good health. A clinical nutritionist is concerned with how nutrients in food are